David Kaunelis
About
In The Last Decade
David Kaunelis
27 papers receiving 224 citations
Peers
Comparison fields: 5 of 76
- General Health Professions 71
- Economics and Econometrics 62
- Physiology 32
- Health, Toxicology and Mutagenesis 31
- Epidemiology 30
Countries citing papers authored by David Kaunelis
This map shows the geographic impact of David Kaunelis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Kaunelis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Kaunelis more than expected).
Fields of papers citing papers by David Kaunelis
This network shows the impact of papers produced by David Kaunelis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Kaunelis. The network helps show where David Kaunelis may publish in the future.
Co-authorship network of co-authors of David Kaunelis
This figure shows the co-authorship network connecting the top 25 collaborators of David Kaunelis. A scholar is included among the top collaborators of David Kaunelis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Kaunelis. David Kaunelis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 3 | |
| 3 | 5 | |
| 4 | 16 | |
| 5 | 3 | |
| 6 | 10 | |
| 7 | 5 | |
| 8 | 8 | |
| 9 | 16 | |
| 10 | 31 | |
| 11 | Patient Perspectives and Experiences Review | 1 |
| 12 | Smoking Cessation Interventions for Patients with Severe Mental Illnesses: A Review of Clinical Effectiveness and Guidelines | 1 |
| 13 | Imiquimod for the Treatment of Basal Cell or Squamous Cell Carcinoma: A Review of Clinical Effectiveness and Cost-Effectiveness | 1 |
| 14 | Drugs for Chronic Hepatitis C Infection: Clinical Review | 3 |
| 15 | PAR-1 Antagonists: An Emerging Antiplatelet Drug Class | 5 |
| 16 | DNA Mismatch Repair Deficiency Tumour Testing for Patients With Colorectal Cancer: A Health Technology Assessment | 1 |
| 17 | Direct-Acting Antiviral Agents for Chronic Hepatitis C Genotype 1 [Internet] | 1 |
| 18 | 52 | |
| 19 | Redesigning a Library Space for Collaborative Learning. | 6 |
| 20 | Literature Reviews: Analysis, Planning, and Query Techniques. | 8 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.